The company’s Phase I trial saw nearly all patients in the trial reaching their targeted maximum dose of DM-101PX.

A team of scientists led by Nanyang Technological University, Singapore (NTU Singapore) have developed "fungi tiles" that ...

Out of the shadows, new CDMO Artis BioSolutions has decloaked on a mission to tackle the tricky production process for ...

Bio-Thera Solutions, the developer of the biosimilar, will continue to hold manufacturing rights in the US market.

Safety scientists are speeding the invention of materials to help harvest water from air, capture carbon and produce hydrogen ...

Lexicon Pharmaceuticals, headquartered in The Woodlands, announced it will exclusively license its drug LX9851 to the maker ...

Experts explain how they work, and how they can be incorporated topically into your routine to make skin look healthier, ...